A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide

Clinical trial NCT00696657 · COMPLETED

Trial details

NCT number: NCT00696657
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Diabetes Mellitus, Type 2

Start date: 2008-06-03
Primary completion: 2009-02-05
Enrollment: 415

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.